Pure Portfolios Holdings’s AbbVie ABBV Stock Holding History

Pure Portfolios Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$256K	Sell	1,121 -11	-1%	-$2.51K	0.08%	91
2025 Q3	$262K	Buy	+1,132	New	+$231K	0.08%	88
2025 Q2	–	Sell	-1,069	Closed	-$224K	–	103
2025 Q1	$224K	Buy	+1,069	New	+$208K	0.08%	91
2024 Q4	–	Sell	-1,098	Closed	-$217K	–	105
2024 Q3	$217K	Buy	+1,098	New	+$205K	0.08%	99

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pure Portfolios Holdings's ABBV Position: Q4 2025 in Review

Pure Portfolios Holdings reduced its AbbVie (ABBV) stake by 0.97% in Q4 2025, selling an estimated $2.51K and leaving 1,121 shares worth $256K. The position accounts for 0.08% of the portfolio, ranked #91.

Pure Portfolios Holdings first reported a position in ABBV in Q3 2024 and has held it in 4 quarters since. The position peaked at $262K in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Pure Portfolios Holdings held 1,121 shares of AbbVie worth $256K as of Q4 2025.
Pure Portfolios Holdings sold 11 AbbVie shares in Q4 2025, an estimated $2.51K.
AbbVie made up 0.08% of Pure Portfolios Holdings's portfolio in Q4 2025, its #91 holding.
Pure Portfolios Holdings first reported a position in AbbVie in Q3 2024 and has held it in 4 quarters since.
Pure Portfolios Holdings's AbbVie position peaked at $262K in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Pure Portfolios Holdings's 13F filing for Q4 2025, filed 30 Jan 2026.